Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00520936 · FLOW

Participant flow

A Study of Pemetrexed in Children With Recurrent Cancer · Source last updated 2011-02-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Pemetrexed 1910 milligrams per meters squared (mg/m\^2) (or 60 milligrams per kilogram \[mg/kg\] if patient \<12 months old)
    id
    FG000
    title
    Osteosarcoma
  2. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG001
    title
    Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumors
  3. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG002
    title
    Rhabdomyosarcoma
  4. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG003
    title
    Neuroblastoma (Measureable Disease)
  5. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG004
    title
    Neuroblastoma (Metaiodobenzylguanidine Positive Evaluable)
  6. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG005
    title
    Ependymoma
  7. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG006
    title
    Medulloblastoma/Supratentorial Primitive Neuroectodermal Tumor
  8. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG007
    title
    Non-Brainstem High-Grade Glioma
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      type
      Physician Decision
    2. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        1
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        2
      8. group Id
        FG007
        num Subjects
        0
      type
      Toxicity Requiring Removal from Study
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        0
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        0
      type
      Protocol Violation
    milestones
    1. achievements
      1. comment
        75 participants entered the study and 72 were enrolled and received study drug.
        group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        11
      3. group Id
        FG002
        num Subjects
        9
      4. group Id
        FG003
        num Subjects
        5
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        10
      7. group Id
        FG006
        num Subjects
        11
      8. group Id
        FG007
        num Subjects
        10
      type
      STARTED
    2. achievements
      1. comment
        Study completion defined as treated until disease progression. Completed=progressive disease.
        group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        7
      4. group Id
        FG003
        num Subjects
        5
      5. group Id
        FG004
        num Subjects
        5
      6. group Id
        FG005
        num Subjects
        10
      7. group Id
        FG006
        num Subjects
        7
      8. group Id
        FG007
        num Subjects
        9
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        2
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Pemetrexed 1910 milligrams per meters squared (mg/m\^2) (or 60 milligrams per kilogram \[mg/kg\] if patient \<12 months old)
    id
    FG000
    title
    Osteosarcoma
  2. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG001
    title
    Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumors
  3. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG002
    title
    Rhabdomyosarcoma
  4. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG003
    title
    Neuroblastoma (Measureable Disease)
  5. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG004
    title
    Neuroblastoma (Metaiodobenzylguanidine Positive Evaluable)
  6. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG005
    title
    Ependymoma
  7. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG006
    title
    Medulloblastoma/Supratentorial Primitive Neuroectodermal Tumor
  8. description
    Pemetrexed 1910 mg/m\^2 (or 60 mg/kg if patient \<12 months old)
    id
    FG007
    title
    Non-Brainstem High-Grade Glioma
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        0
      type
      Physician Decision
    2. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        0
      8. group Id
        FG007
        num Subjects
        1
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        2
      8. group Id
        FG007
        num Subjects
        0
      type
      Toxicity Requiring Removal from Study
    4. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        0
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        1
      8. group Id
        FG007
        num Subjects
        0
      type
      Protocol Violation
    milestones
    1. achievements
      1. comment
        75 participants entered the study and 72 were enrolled and received study drug.
        group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        11
      3. group Id
        FG002
        num Subjects
        9
      4. group Id
        FG003
        num Subjects
        5
      5. group Id
        FG004
        num Subjects
        6
      6. group Id
        FG005
        num Subjects
        10
      7. group Id
        FG006
        num Subjects
        11
      8. group Id
        FG007
        num Subjects
        10
      type
      STARTED
    2. achievements
      1. comment
        Study completion defined as treated until disease progression. Completed=progressive disease.
        group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        7
      4. group Id
        FG003
        num Subjects
        5
      5. group Id
        FG004
        num Subjects
        5
      6. group Id
        FG005
        num Subjects
        10
      7. group Id
        FG006
        num Subjects
        7
      8. group Id
        FG007
        num Subjects
        9
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        2
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        1
      6. group Id
        FG005
        num Subjects
        0
      7. group Id
        FG006
        num Subjects
        4
      8. group Id
        FG007
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice